Recurrent Superficial Bladder Cancer (DBCOND0042708)

Identifiers

Synonyms

Superficial, recurrent Bladder Cancer

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
BCG vaccine	A vaccine indicated in the prevention of tuberculosis and the treatment of non-invasive urothelial bladder cancer.	No drug targets
Epirubicin	An anthracycline topoisomerase II inhibitor used as an adjuvant to treating axillary node metastases in patients who have undergone surgical resection of primary breast cancer.	DNA topoisomerase 2-alphatarget DNAtarget Multidrug resistance-associated protein 1transporter UDP-glucuronosyltransferase 2B7enzyme Cytosolic phospholipase A2enzyme DNA topoisomerase 2-betatarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00816075	Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection	No drug interventions	prevention	2 / 3	unknown_status